1-10 of 10
Authors: Magdalena A Taracila
Sort by
Journal Article
P-788. Exploring β-Lactam Interactions with DacB1: Unraveling Optimal Therapies for Combating Drug-Resistant Mycobacterium tuberculosis Open Access
Mary Nantongo and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.982, https://doi.org/10.1093/ofid/ofae631.982
Published: 29 January 2025
Journal Article
2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin-binding-proteins binding by imipenem, ceftaroline, and amoxicillin Open Access
Eunjeong Shin and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2417, https://doi.org/10.1093/ofid/ofad500.2417
Published: 27 November 2023
Journal Article
1432. Exploring Cell Wall Targets to Overcome Mycobacterium tuberculosis (Mtb): Ceftriaxone (CRO) Inhibits LdtMt2, a Major Peptidoglycan (PG) Synthase Open Access
David C Nguyen and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1261, https://doi.org/10.1093/ofid/ofac492.1261
Published: 15 December 2022
Journal Article
1445. Deciphering the Role of the Y221H Ω-loop Substitution in Pseudomonas-derived Cephalosporinase (PDC) in Cephalosporin Resistance Open Access
Andrew R Mack and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S725–S726, https://doi.org/10.1093/ofid/ofaa439.1626
Published: 31 December 2020
Journal Article
1250. Novel Boronic Acid Transition State Analogs (BATSI) with in vitro inhibitory activity against class A, B and C β-lactamases Open Access
Maria F Mojica and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S643, https://doi.org/10.1093/ofid/ofaa439.1434
Published: 31 December 2020
Journal Article
1256. In Vivo Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and Acinetobacter spp Open Access
Joel Goldberg and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S645, https://doi.org/10.1093/ofid/ofaa439.1440
Published: 31 December 2020
Journal Article
1437. Biochemical characterization of L1 and L2 β-lactamases from clinical isolates of Stenotrophomonas maltophilia Open Access
Maria F Mojica and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S723, https://doi.org/10.1093/ofid/ofaa439.1618
Published: 31 December 2020
Journal Article
1572. Combination Cefuroxime and Sulopenem is active in vitro against Mycobacterium abscessus Open Access
Khalid M Dousa and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S785, https://doi.org/10.1093/ofid/ofaa439.1752
Published: 31 December 2020
Journal Article
698. Nacubactam Inhibits Class A β-lactamases Open Access
Melissa D Barnes and others
Open Forum Infectious Diseases, Volume 5, Issue suppl_1, November 2018, Pages S251–S252, https://doi.org/10.1093/ofid/ofy210.705
Published: 26 November 2018
Journal Article
AAI101, a Novel β-Lactamase Inhibitor: Microbiological and Enzymatic Profiling Open Access
Krisztina M Papp-Wallace and others
Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Page S375, https://doi.org/10.1093/ofid/ofx163.924
Published: 04 October 2017
Advertisement
Advertisement